Dr. Silberman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
508 Fulton St
Durham, NC 27705Phone+1 828-257-2333
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1992
NYU Grossman School of MedicineResidency, Internal Medicine, 1985 - 1987
Weill Cornell MedicineClass of 1985
Certifications & Licensure
NC State Medical License 2016 - 2023
NJ State Medical License 2002 - 2017
CT State Medical License 1992 - 2005- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients Start of enrollment: 2004 Feb 01
- Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies Start of enrollment: 2005 Nov 01
- A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.Samuel A Goldlust, Louis B Nabors, Sigmund Hsu, Nimish Mohile, Paul J Duic
Neuro-Oncology Advances. 2024-01-18 - 1 citationsSpliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refra...Peter J P Croucher, Maya Ridinger, Pamela S Becker, Tara L Lin, Sandra L Silberman
Annals of Hematology. 2023-11-01 - 2 citationsKinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor.Michael C Heinrich, Christopher L Corless, George D Demetri, Charles D Blanke, Margaret von Mehren
Journal of Clinical Oncology. 2023-11-01
Press Mentions
Moleculin Announces Publication of Data Supporting Development of Non-Cardiotoxic Anthracycline for the Treatment of Cancer in Peer-Reviewed European Journal of CancerMarch 9th, 2023- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Has Potential to Make History in Battle Against Deadly Brain Cancer with BerubicinDecember 12th, 2022
- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expanding Scope of Potentially Pivotal Study as Part of Clinical Program to Develop GBM TreatmentAugust 2nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
